Giorgio Candotti - Publications

When less is more: perioperative and oncological outcomes of avoiding hysterectomy in selected patients with early-stage epithelial ovarian cancer.

Journal: European journal of obstetrics, gynecology, and reproductive biology

Published: June 26, 2026

[18F]FDG PET/MRI in Endometrial Cancer: Prospective Evaluation of Preoperative Staging, Molecular Characterization and Prognostic Assessment.

Journal: Cancers

Published: December 09, 2025

Modified Davydov Neovaginoplasty in Patients With Mayer-Rokitansky-Kuster-Hauser Syndrome: Outcomes From an Extensive Surgical Experience.

Journal: Journal of minimally invasive gynecology

Published: August 14, 2025

Endometrioid borderline ovarian tumour: A multicentre analysis from the MITO-14 study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: January 13, 2025

Evaluation of Different Risk Factors for Metastatic Sentinel Lymph Nodes in Endometrial Cancer.

Journal: Cancers

Published: October 10, 2024

A randomized controlled trial on the oncologic outcomes of use of the intrauterine manipulator in the treatment of apparent uterine-confined endometrial carcinoma: the MANEC Trial.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: September 12, 2024

Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells.

Journal: Frontiers in immunology

Published: April 26, 2023

Endometriosis-Related Ovarian Cancers: Evidence for a Dichotomy in the Histogenesis of the Two Associated Histotypes.

Journal: Diagnostics (Basel, Switzerland)

Published: February 27, 2023

Sentinel lymph node biopsy in open surgery for gynecological malignancies.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: December 23, 2022

Experimental drugs for fallopian cancer: promising agents in the clinical trials and key stumbling blocks for researchers.

Journal: Expert opinion on investigational drugs

Published: December 20, 2022

Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness.

Journal: Cancers

Published: December 02, 2022

Ovarian Cancer Radiosensitivity: What Have We Understood So Far?

Journal: Life (Basel, Switzerland)

Published: November 08, 2022